首页 | 本学科首页   官方微博 | 高级检索  
     

2011ŷ�����ಡѧ�������Ѫ�ܼ�����ϸ�������½�չ
引用本文:吴炜,张抒扬. 2011ŷ�����ಡѧ�������Ѫ�ܼ�����ϸ�������½�չ[J]. 中国实用内科杂志, 2011, 31(10): 763-764
作者姓名:吴炜  张抒扬
作者单位:中国医学科学院中国协和医科大学北京协和医院心内科;
摘    要:细胞移植治疗缺血性心肌病是近10年来心血管疾病治疗的热点。随着骨髓干细胞的临床试验数据逐步积累,欧洲心脏病学会年会公布了骨髓干细胞治疗的有效性和安全性,总结其在移植干细胞类型和数量、移植方式和时机、适合人群方面的特点,指出目前的临床研究已经从急性心肌梗死逐步转向心力衰竭患者,并提出了另一种新型诱导多能干细胞的良好远景。

关 键 词:干细胞  心肌梗死  心力衰竭

Update of stem cells therapy for cardiovascular disease from European Society of Cardiology
WU Wei,ZHANG Shu-yang. Update of stem cells therapy for cardiovascular disease from European Society of Cardiology[J]. Chinese Journal of Practical Internal Medicine, 2011, 31(10): 763-764
Authors:WU Wei  ZHANG Shu-yang
Affiliation:WU Wei,ZHANG Shu-yang.Department of Cardiology,Chinese Academy of Medical Science,Peking Union Medical College,Peking Union Medical College Hospital,Beijing 100730,China
Abstract:Stem cell transplantation therapy for ischemic cardiomyopathy remains to be the central issue in cardiovascular disease treatment in recent decade.With the accumulation of clinical data on bone marrow stem cells treatment,European Society of Cardiology(ESC) has announced its efficacy and safety.ESC summarized the characteristics of reasonable stem cell types,cell numbers,timing and method of delivery and appropriate popula-tion.It figured out that new clinical trials were conducted on patients with chronic ...
Keywords:stem cell  myocardial infarction  heart failure  
本文献已被 CNKI 等数据库收录!
点击此处可从《中国实用内科杂志》浏览原始摘要信息
点击此处可从《中国实用内科杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号